文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

作者信息

Powles T, Bellmunt J, Comperat E, De Santis M, Huddart R, Loriot Y, Necchi A, Valderrama B P, Ravaud A, Shariat S F, Szabados B, van der Heijden M S, Gillessen S

机构信息

Barts Cancer Centre, Barts Health NHS Trust, Queen Mary University of London, London, UK.

Beth Israel Deaconess Medical Centre-IMIM Lab, Harvard Medical School, Boston, USA.

出版信息

Ann Oncol. 2022 Mar;33(3):244-258. doi: 10.1016/j.annonc.2021.11.012. Epub 2021 Nov 30.

DOI:10.1016/j.annonc.2021.11.012
PMID:34861372
Abstract
摘要

相似文献

[1]
Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Ann Oncol. 2022-3

[2]
[Innovations in systemic treatment of urothelial carcinoma].

Bull Cancer. 2020-6

[3]
ESMO Clinical Practice Guideline interim update on first-line therapy in advanced urothelial carcinoma.

Ann Oncol. 2024-6

[4]
Evolving systemic management of urothelial cancers.

Curr Opin Oncol. 2023-5-1

[5]
Current Therapy for Metastatic Urothelial Carcinoma.

Hematol Oncol Clin North Am. 2021-6

[6]
The Evolving Landscape of Antibody-Drug Conjugates for Urothelial Carcinoma.

Clin Genitourin Cancer. 2021-6

[7]
Emerging strategies for the improvement of chemotherapy in bladder cancer: Current knowledge and future perspectives.

J Adv Res. 2022-7

[8]
A novel strategy for treatment of bladder cancer: Antibody-drug conjugates.

Investig Clin Urol. 2022-7

[9]
An update on antibody-drug conjugates in urothelial carcinoma: state of the art strategies and what comes next.

Cancer Chemother Pharmacol. 2022-9

[10]
[Antibody-drug conjugates as new therapeutic agents in uro-oncology].

Urologie. 2023-7

引用本文的文献

[1]
Advances in the immunological microenvironment and immunotherapy of bladder cancer.

Front Immunol. 2025-8-19

[2]
Rare Case of Large Bowel Obstruction due to Plasmacytoid Urothelial Carcinoma.

Surg Case Rep. 2025

[3]
Urinary bladder cancer needs more attention - recommendations for health care professionals and politicians in the European Union.

Nat Rev Urol. 2025-8-19

[4]
Exploring Natural Products to Target Ferroptosis in Urologic Malignancies: Advancements from Molecular Mechanisms to Therapeutic Strategies.

Chin J Integr Med. 2025-8-13

[5]
Editorial: Multidisciplinary management of urological malignancies in the era of precision medicine: integration of advances in technology and cancer care.

Front Urol. 2025-1-8

[6]
Oncological and functional outcomes and complications of robotic intracorporeal Studer orthotopic neobladder: A single-center retrospective study.

Bladder (San Franc). 2025-1-9

[7]
Oncological outcomes of open versus minimally invasive nephroureterectomy for locally advanced upper tract urothelial carcinoma.

World J Urol. 2025-7-23

[8]
The impact of METTL3 on bladder cancer through mA modification: a potential therapeutic target and prognostic biomarker.

Front Oncol. 2025-7-3

[9]
The role of DNA methylation and demethylation in bladder cancer: a focus on therapeutic strategies.

Front Oncol. 2025-6-26

[10]
Brain metastasis in a patient with metastatic urothelial carcinoma after 7 years of avelumab maintenance therapy: A case report.

Urol Case Rep. 2025-6-16

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索